| RBL2 |
RBL2, RB2: Retinoblastoma-like protein 2 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
8.867 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
CAMK1 |
CAMK1: Calcium/calmodulin-dependent protein kinase type 1 |
8.867 |
Evidence |
|
| DAB2 |
DAB2, DOC2: Disabled homolog 2 |
SOS1 |
SOS1: Son of sevenless homolog 1 |
8.867 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
HSPB8 |
HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 |
8.867 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
HPCA |
HPCA, BDR2: Neuron-specific calcium-binding protein hippocalcin |
8.867 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
RDX |
RDX: Radixin |
8.867 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
DAB2 |
DAB2, DOC2: Disabled homolog 2 |
8.867 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
8.867 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
RIN1 |
RIN1: Ras and Rab interactor 1 |
8.867 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
8.867 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
DAB2 |
DAB2, DOC2: Disabled homolog 2 |
8.867 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
8.867 |
Evidence |
|
| RFX1 |
RFX1: MHC class II regulatory factor RFX1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
8.867 |
Evidence |
|
| EGR1 |
EGR1, ZNF225: Early growth response protein 1 |
ZBTB16 |
ZBTB16, PLZF, ZNF145: Zinc finger and BTB domain-containing protein 16 |
8.867 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
8.867 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
CSK |
CSK: Tyrosine-protein kinase CSK |
8.867 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
8.867 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
RDX |
RDX: Radixin |
8.867 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
HPCA |
HPCA, BDR2: Neuron-specific calcium-binding protein hippocalcin |
8.867 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
8.867 |
Evidence |
|
| VIL2 |
IPI00479359 |
RDX |
RDX: Radixin |
8.867 |
Evidence |
O
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
8.867 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
EPHA2 |
EPHA2, ECK: Ephrin type-A receptor 2 precursor |
8.867 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
PRKAR2B |
IPI00456775 |
8.867 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
DAB2 |
DAB2, DOC2: Disabled homolog 2 |
8.867 |
Evidence |
|